NYT Articles – Our Response
Claritev is aware of the articles recently published by the New York Times and fundamentally disagrees with the depiction of our position in the industry and the services that we provide. Read our full statement here >
MultiPlan Reports Fourth Quarter and Full Year 2022 Results
– Q4 2022 Revenues of $241.1 million, Net Loss of $650.1 million (including a $662.2 million impairment of goodwill and indefinite-lived intangible assets) and Adjusted EBITDA of $161.5 million – Full Year 2022 Revenues of $1,079.7 million, Net Loss of $572.9 million (including a $662.2 million impairment of goodwill and indefinite-lived intangible assets) and Adjusted EBITDA of $768.7 […]
MultiPlan Announces $100 Million Share Repurchase Program
NEW YORK – MultiPlan Corporation (NYSE:MPLN) (“MultiPlan” or the “Company”), a leading provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today announced that its Board of Directors has approved a new share repurchase program authorizing the Company to repurchase up to $100 million of its […]
MultiPlan Corporation Announces Participation at Upcoming Conferences
NEW YORK – MultiPlan Corporation (NYSE:MPLN) (“MultiPlan” or the “Company”), a leading provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today announced that members of its management team will participate in person at the following conferences in March 2023: Citi’s 2023 Healthcare Services, Medtech, […]
